(S1 (S (NP (NN PTX)) (VP (VBZ decreases) (NP (JJ LPS-induced) (NN NF-kappaB) (NN activation)))))
(S1 (S (S (SBAR (IN Since) (S (NP (NN phosphorylation)) (VP (VBZ leads) (PP (TO to) (NP (NP (NP (NP (NN ubiquitination)) (CC and) (NP (NN degradation))) (PP (IN of) (NP (NN I-kappaBalpha)))) (CC and) (NP (NP (JJ subsequent) (JJ nuclear) (NN translocation)) (PP (IN of) (NP (NN NF-kappaB))))))))) (, ,) (NP (PRP we)) (ADVP (RB first)) (VP (VBD examined) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN PTX))) (PP (IN on) (NP (NN I-kappaBalpha)))))) (. .)))
(S1 (S (S (NP (JJ Cytoplasmic) (NN I-kappaBalpha) (NN phosphorylation)) (VP (VBD was) (ADVP (RB markedly)) (VP (VBN increased) (PP (VBG following) (NP (NN LPS) (NN stimulation)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (TO to) (NP (NP (NN control)) (PRN (-LRB- -LRB-) (QP (QP (CD 100) (CC +/-) (CD 0)) (CC vs.) (QP (CD 20) (CC +/-) (CD 18))) (: ;) (NP (NN P) (NN <) (CD 0.05)) (-RRB- -RRB-))))))))) (. .)))
(S1 (S (NP (NP (DT The) (NN addition)) (PP (IN of) (NP (NN PTX)))) (ADVP (RB significantly)) (VP (VBD downregulated) (NP (JJ LPS-induced) (NN I-kappaBalpha) (NN phosphorylation)) (PRN (-LRB- -LRB-) (S (NP (NN P)) (VP (JJ =) (NP (NP (CD 0.02)) (: ;) (NP (NN Figure) (CD 2))))) (-RRB- -RRB-)))))
(S1 (S (PP (IN In) (NP (DT a) (JJ similar) (NN fashion))) (, ,) (NP (JJ nuclear) (NN NF-kappaB) (NN p65) (NN phosphorylation)) (VP (VBD was) (VP (VBN increased) (PP (VBG following) (NP (NN LPS) (NN stimulation))) (PRN (-LRB- -LRB-) (QP (CD 100) (CC +/-) (CD 0) (CC vs.) (CD 38) (CC +/-) (CD 20)) (: ;) (NP (NN P) (NN <) (CD 0.01)) (-RRB- -RRB-)))) (. .)))
(S1 (S (S (NP (NN PTX)) (ADVP (RB similarly)) (VP (VBD decreased) (NP (NP (JJ LPS-induced) (NN NF-kappaB) (NN p65) (JJ nuclear) (NN phosphorylation)) (, ,) (NP (NP (DT a) (NN marker)) (PP (IN of) (NP (NN NF-kappaB) (NN activation)))) (CC and) (NP (NP (JJ nuclear) (NN translocation)) (PRN (-LRB- -LRB-) (NP (QP (CD 100) (CC +/-) (CD 0) (CC vs.) (CD 40) (CC +/-) (CD 6)) (: ;) (NP (NN P) (CD =0.03)) (: ;) (NP (NN Figure) (NN 3A))) (-RRB- -RRB-)))))) (. .)))
(S1 (S (S (NP (NNS EMSAs)) (VP (VBD were) (ADVP (RB then)) (VP (VBN performed) (S (VP (TO to) (VP (VB verify) (NP (NP (DT the) (JJ PTX-induced) (NNS alterations)) (PP (IN in) (NP (NP (JJ nuclear) (NN phosphorylation)) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ similar) (NNS effects)) (PP (IN on) (NP (NP (DT the) (NN DNA) (NN binding) (NN activity)) (PP (IN of) (NP (NN NF-kappaB))))))))))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN addition)) (PP (IN of) (NP (NN PTX))) (PP (TO to) (NP (JJ LPS-stimulated) (JJ mononuclear) (NNS cells)))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ comparable) (NN downregulation)) (PP (IN of) (NP (NN DNA) (NN binding) (NN activity))))) (, ,) (ADJP (ADJP (JJ similar) (PP (TO to) (NP (NP (DT the) (VBN observed) (NN downregulation)) (PP (IN of) (NP (NN NF-kappaB) (NN phosphorylation)))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3B)) (-RRB- -RRB-))))) (. .)))
